BIOVECTRA, a part of Agilent Technologies Inc., and Revolution Biomanufacturing Inc. today announced a collaboration that ...
Moderna Inc became the second U.S company to release data from a large study of its experimental vaccine, saying it was 94.5% effective against COVID-19.
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback